AngioDynamics, Inc. (ANGO) Tops Q1 EPS by 1c; Lowers FY13 EPS outlook
AngioDynamics, Inc. (NASDAQ: ANGO) reported Q1 EPS of $0.10, $0.01 better than the analyst estimate of $0.09. Revenue for the quarter came in at $83.4 million versus the consensus estimate of $84.35 million.
AngioDynamics, Inc. sees FY2013 EPS of $0.40-0.42, versus the consensus of $0.50.
For earnings history and earnings-related data on AngioDynamics, Inc. (ANGO) click here.
AngioDynamics, Inc. sees FY2013 EPS of $0.40-0.42, versus the consensus of $0.50.
For earnings history and earnings-related data on AngioDynamics, Inc. (ANGO) click here.